Inductive Bio is a privately held biotechnology research organization focused on chemical intelligence for drug discovery. It developed Indy, an artificial intelligence chemistry assistant designed to aid medicinal chemists.
Subscribe to see Inductive Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Inductive Bio, Inc. is an ai/ml company headquartered in United States. It has raised at least $29.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $25M in May 2025. Xcout tracks 9 named people at Inductive Bio, Inc., including Joshua Haimson (Chief Executive Officer). Xcout recorded 9 job postings from Inductive Bio, Inc. in the last 90 days, naming tools such as PyTorch, scikit-learn, TensorFlow.
3 more named people on record for Inductive Bio, Inc., with roles, board committees and tenure — see the full roster →
At least $29.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $25M | 12 named | |
| Series A | $4.3M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 9 job postings from Inductive Bio, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Inductive Bio, Inc.'s hiring signals →
A few of Inductive Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
BenevolentAI provides an artificial intelligence platform and life science intelligence tools designed to assist scientists and pharmaceutical executives in drug discovery and research and development decision-making. The company leverages proprietary technology and machine learning to analyze biological data and support complex R&D processes.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
PostEra is an AI-first biotechnology company utilizing its proprietary Proton platform for medicinal chemistry to discover and develop new medicines for patients. The company operates out of Boston and Cambridge, Massachusetts.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Insitro is a physical artificial intelligence company headquartered in South San Francisco, California, that uses machine learning and data at scale to build a different kind of drug company.
Standigm provides artificial intelligence-driven platforms and software-as-a-service (SaaS) solutions for drug discovery. The company serves pharmaceutical and biotechnology researchers by offering tools for novel target identification, lead optimization, and ADMET prediction.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Inductive Bio, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.